A novel electrochemical nanosensor based on NH2-functionalized multi walled carbon nanotubes for the determination of catechol-orto-methyltransferase inhibitor Entacapone (cas 116314-67-1)
-
Add time:08/05/2019 Source:sciencedirect.com
In this study, an antiparkinson drug Entacapone (ENP) is electrochemically investigated under optimized conditions using NH2 functionalized multi walled carbon nanotubes (NH2fMWCNT) decorated over glassy carbon electrode (GCE). The surface morphology of the NH2fMWCNT/GCE was probed by scanning electron microscopy (SEM) armed with EDX analysis. Electrochemical impedance spectroscopy (EIS) was employed to investigate the electron transfer capability of modified and bare electrodes. Cyclic voltammetry was used to compare the redox response of ENP on the surface of modified and unmodified electrodes. The influence of interfering agents was also studied to examine the selectivity of the designed sensor. For the purpose of practical applicability of the proposed method, differential pulse voltammetric method was applied for the investigation of ENP in real samples i.e., tablet, human serum and urine. Almost 100% recovery percentages were obtained from tablet, serum and urine samples with RSD% values of less than 2% for all the samples, thus, suggesting promising applicability of the designed electrochemical sensing platform (NH2fMWCNT/GCE) for determination of ENP in pharmaceutical dosage and real samples.
We also recommend Trading Suppliers and Manufacturers of Entacapone (cas 116314-67-1). Pls Click Website Link as below: cas 116314-67-1 suppliers
Prev:Use of an Entacapone (cas 116314-67-1)-containing drug combination and risk of death: Analysis of the FDA AERS (FAERS) database
Next:The catechol-O-methyltransferase inhibitors tolcapone and Entacapone (cas 116314-67-1) uncouple and inhibit the mitochondrial respiratory chain in HepaRG cells) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- The catechol-O-methyltransferase inhibitors tolcapone and Entacapone (cas 116314-67-1) uncouple and inhibit the mitochondrial respiratory chain in HepaRG cells08/06/2019
- Use of an Entacapone (cas 116314-67-1)-containing drug combination and risk of death: Analysis of the FDA AERS (FAERS) database08/04/2019
- Micellar HPLC-UV method for the simultaneous determination of levodopa, carbidopa and Entacapone (cas 116314-67-1) in pharmaceuticals and human plasma08/03/2019
- Entacapone (cas 116314-67-1) and prostate cancer in Parkinson's disease patients: A large Veterans Affairs healthcare system study08/02/2019